Association between genetic variation at the APO AI‐CIII‐AIV gene cluster and familial combined hyperlipidaemia
- 1 December 1994
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 46 (6) , 385-397
- https://doi.org/10.1111/j.1399-0004.1994.tb04404.x
Abstract
By using chemical cleavage mismatch analysis and the single strand conformation polymorphism technique, DNA fragments of the apo CIII gene, including the 5′ flanking region and all the exons, were screened for sequence changes underlying the observed association between familial combined hyperlipidaemia (FCHL) and the apo AI‐CIII‐AIV gene cluster in affected individuals from eight FCHL families. A C1100‐T transition in the wobble position of codon 14 in exon 3 and a T3206‐G transversion in the non‐translated region of exon 4 were identified, occurring in four and all probands, respectively. Using these variants and the G_75‐A transition in the apo AI promoter, co‐segregation of the gene cluster with hyperlipidaemia could be excluded in all eight families (lod score ‐∞ at θ=0). No support for co‐segregation was obtained using the affected pedigree member method of linkage analysis (overall T=–0.77 for f (p)=1√p). The frequencies of T1100 and G3206 in a group of 55 patients with combined hyperlipidaemia were 0.35 and 0.52, respectively, which were significantly higher compared to 360 controls (0.21, p1100 allele, levels of plasma triglyceride were 2.5‐fold higher (868 mg/dl) than those homozygous for the C1100 allele (337 mg/dl), while patients heterozygous for the polymorphism had intermediate values (443 mg/dl) (p<0.01). A similar association was seen in controls (p<0.04). The three polymorphisms studied were in strong linkage disequilibrium in both the group of CHL patients and the unrelated individuals. This study confirms the association between common variation in the gene cluster and differences in plasma lipid levels in the general population and in patients with combined hyperlipidaemia, but fails to confirm co‐segregation with FCHL, suggesting the role of other genetic or environmental factors in the aetiology of FCHL.Keywords
This publication has 52 references indexed in Scilit:
- Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.Journal of Clinical Investigation, 1993
- Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.Journal of Clinical Investigation, 1990
- Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and EAtherosclerosis, 1990
- Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.Journal of Clinical Investigation, 1986
- A study of DNA polymorphisms around the human apolipoprotein Al gene in hyperlipidaemic and normal individualsClinical Genetics, 1985
- Isolation and Sequence Analysis of the Human Apolipoprotein CIII Gene and the Intergenic Region between the Apo AI and Apo CIII GenesDNA, 1984
- Cholesterin und Triglyceride im Serum einer Münchner Bevölkerungsgruppe: Beziehungen zu Alter und Geschlechtcclm, 1981
- Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemiaEuropean Journal of Clinical Investigation, 1980
- Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoproteinBiochemical and Biophysical Research Communications, 1972